Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ASEAN Signs MRA To Ensure All Exports Meet GMP Standards In Southeast Asia By 2011

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - With an eye on developing a stronger regional pharmaceutical market, 10 countries in Southeast Asia are moving to eliminate trade barriers and improve drug safety by creating standard manufacturing and licensing processes

You may also be interested in...



Asia Raises Bar for New Drugs, Manufacturers With Tougher CMC Reviews, GMP Inspections (Part 1)

As Asian drug regulatory authorities gain confidence in their ability to regulate new drug products, they are subjecting applicants to increasingly extensive chemistry, manufacturing and controls reviews, more like those of first-tier authorities in the U.S. and Europe

Asia Raises Bar for New Drugs, Manufacturers With Tougher CMC Reviews, GMP Inspections (Part 1)

As Asian drug regulatory authorities gain confidence in their ability to regulate new drug products, they are subjecting applicants to increasingly extensive chemistry, manufacturing and controls reviews, more like those of first-tier authorities in the U.S. and Europe

Government-funded BiotechCorp Senior VP For Healthcare Selvam Ramaraj On Malaysia’s Biotech Expansion Plans: An Interview With PharmAsia News (Part 2 of 2)

Malaysiahas identified the biotechnology industry as one of the key drivers of growth in transforming the country into a knowledge-based economy, and the government is fully committed to its development. As part of that commitment, the government set up the Malaysian Biotechnology Corporation (BiotechCorp) in 2005, as one of the action plans under the National Biotechnology Policy, under the purview of the Ministry of Science, Technology and Innovation. BiotechCorp's goal is to identify value propositions in both R&D and commerce and support these ventures via financial assistance and other means. BiotechCorp Senior Vice President for Healthcare Selvam Ramaraj recently talked with PharmAsia News about the company and its master plans for Malaysia.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071356

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel